Cargando…
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
OBJECTIVE: To study the risk of acquiring Corona Virus Disease 2019 (COVID-19) and its outcomes in patients on immunosuppressive therapy (IST) for chronic autoimmune neuromuscular disorders (aNMD) and multiple sclerosis (MS). METHODS: We used TriNetX, a global health collaborative clinical research...
Autores principales: | Kovvuru, Sukanthi, Nalleballe, Krishna, Onteddu, Sanjeeva Reddy, Sharma, Rohan, Jasti, Madhu, Kapoor, Nidhi, Veerapaneni, Karthika, Yadala, Sisira, Dandu, Vasuki, Archer, Robert, Nowak, Richard J., Roy, Bhaskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837234/ https://www.ncbi.nlm.nih.gov/pubmed/33256952 http://dx.doi.org/10.1016/j.jns.2020.117230 |
Ejemplares similares
-
Spectrum of neuropsychiatric manifestations in COVID-19
por: Nalleballe, Krishna, et al.
Publicado: (2020) -
Resident Education During COVID-19 Pandemic: Effectiveness of Virtual Electroencephalogram Learning
por: Yadala, Sisira, et al.
Publicado: (2020) -
COVID-19 in patients with neurological disorders
por: Onteddu, Sanjeeva Reddy, et al.
Publicado: (2020) -
A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018
por: Dandu, Vasuki, et al.
Publicado: (2020) -
Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
por: Nalleballe, Krishna, et al.
Publicado: (2020)